In turn, several studies have reported that the Ado produced by the functional activity of ectonucleotidases CD39 and CD73 participates in the suppression of the antitumor immune response and favors tumor progression in several types of cancer [14, 41–43]. The gene discussed is ENTPD1; the disease is cancer.